ES2096934T3 - Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion. - Google Patents

Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion.

Info

Publication number
ES2096934T3
ES2096934T3 ES93916290T ES93916290T ES2096934T3 ES 2096934 T3 ES2096934 T3 ES 2096934T3 ES 93916290 T ES93916290 T ES 93916290T ES 93916290 T ES93916290 T ES 93916290T ES 2096934 T3 ES2096934 T3 ES 2096934T3
Authority
ES
Spain
Prior art keywords
composition
glucan
pct
active substance
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916290T
Other languages
English (en)
Inventor
Arie Cornelis Besemer
Der Lugt Jan Pieter Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Application granted granted Critical
Publication of ES2096934T3 publication Critical patent/ES2096934T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EN LA INVENCION SE PRESENTA UNA COMPOSICION PARA LA LIBERACION RETARDADA DE UNA SUSTANCIA ACTIVA, EN DONDE LA SUSTANCIA ACTIVA SE ENCUENTRA INCORPORADA EN UNA MATRIZ POLISACARIDA QUE CONSISTE EN UN GLUCANO DE CADENA RECTA ESENCIALMENTE CRISTALINO Y QUE CONTIENE UN AGENTE DEGRADADOR DEL GLUCANO. EL GLUCANO ES EN PARTICULAR UN (ALFA)GLUCANO QUE TIENE ESENCIALMENTE UNA ESTRUCTURA HELICOIDAL. EL AGENTE DEGRADADOR DEL GLUCANO ES PREFERENTEMENTE UNA (ALFA)-AMILASA. LA COMPOSICION PUEDE CONTENER MATERIALES DE ALTO PESO MOLECULAR TALES COMO PROTEINAS, ALERGENOS, SUSTANCIAS PARA VACUNAS Y MICROORGANISMOS, Y PREFERENTEMENTE SE PRESENTAN COMO COMPRIMIDOS.
ES93916290T 1992-07-03 1993-07-02 Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion. Expired - Lifetime ES2096934T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9201196A NL9201196A (nl) 1992-07-03 1992-07-03 Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.

Publications (1)

Publication Number Publication Date
ES2096934T3 true ES2096934T3 (es) 1997-03-16

Family

ID=19861015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916290T Expired - Lifetime ES2096934T3 (es) 1992-07-03 1993-07-02 Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion.

Country Status (12)

Country Link
US (1) US5629018A (es)
EP (1) EP0648115B1 (es)
JP (1) JPH07508532A (es)
AT (1) ATE145821T1 (es)
AU (1) AU677591B2 (es)
CA (1) CA2139493A1 (es)
DE (1) DE69306390T2 (es)
DK (1) DK0648115T3 (es)
ES (1) ES2096934T3 (es)
GR (1) GR3022646T3 (es)
NL (1) NL9201196A (es)
WO (1) WO1994001091A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19737481A1 (de) 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
WO1999030691A2 (en) * 1997-12-18 1999-06-24 Ato B.V. Composition for the controlled release of active compounds
DE19860373B4 (de) * 1998-12-28 2004-02-19 Celanese Ventures Gmbh Mundpflegemittel und Verwendung von sphärischen Mikropartikeln
JP3742335B2 (ja) * 2001-12-20 2006-02-01 富士通株式会社 入出力バッファ回路
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
US6890571B2 (en) * 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
US6929817B2 (en) * 2002-05-14 2005-08-16 National Starch & Chemical Investment Holding Corporation Slowly digestible starch product
US9101155B2 (en) 2003-07-11 2015-08-11 Asahi Kasei Chemicals Corporation Functional starch powder
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US20070071810A1 (en) * 2003-08-26 2007-03-29 Kenichi Kudo Additive for tablets
JPWO2006082968A1 (ja) * 2005-02-07 2008-06-26 江崎グリコ株式会社 α−１，４−グルカンを含有する吸着剤およびその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US4859377A (en) * 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens

Also Published As

Publication number Publication date
US5629018A (en) 1997-05-13
GR3022646T3 (en) 1997-05-31
DE69306390T2 (de) 1997-06-05
EP0648115B1 (en) 1996-12-04
ATE145821T1 (de) 1996-12-15
AU4589293A (en) 1994-01-31
JPH07508532A (ja) 1995-09-21
DE69306390D1 (de) 1997-01-16
AU677591B2 (en) 1997-05-01
CA2139493A1 (en) 1994-01-20
EP0648115A1 (en) 1995-04-19
DK0648115T3 (da) 1997-06-02
WO1994001091A1 (en) 1994-01-20
NL9201196A (nl) 1994-02-01

Similar Documents

Publication Publication Date Title
ES2096934T3 (es) Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion.
US6124273A (en) Chitin hydrogels, methods of their production and use
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
DK0789559T4 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
ES2042700T3 (es) Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
MY114388A (en) Multiple unit pharmaceutical preparation
EP0402031A3 (en) Injectable polymeric bodies
BR9104280A (pt) Composicao farmaceutica e processo para a preparacao de uma composicao
ATE240719T1 (de) Pharmazeutische tablette mit verzögerter freisetzung, enthaltend eine matrix aus quervernetzter amylose und hydroxypropyl methylzellulose
PT78434B (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
CA2263557A1 (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
GR3022195T3 (en) Composition for controlled release of an active substance and method for the preparation of such a composition.
HUP9802498A2 (hu) Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
AU3844995A (en) Implantable device for administration of active substances to plants
ATE237331T1 (de) Deuterierte wirkstoffe in transdermaler applikation
CA2027833A1 (en) Implant material, method for the manufacture thereof and procedure for the application of the material
PL315619A1 (en) Oral form of a drug containing acid active substances and method of obtaining same
EP0371733A3 (en) Dopamine-beta-hydroxylase inhibitors
AU7533394A (en) Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
PL321159A1 (en) Novel peptidic active substance and method of obtaining same
陈受谦 et al. Experimental Observation on Osteogenetic Effects of Allogenic Decalcified Bone Matrix
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
ES8601689A1 (es) Procedimiento de preparar composiciones farmaceuticas solidas de liberacion sostenida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 648115

Country of ref document: ES